Centiva Capital’s Calidi Biotherapeutics CLDI Stock Holding History

Centiva Capital’s Portfolio CLDI Stock Details CLDI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,667	Closed	-$1.99M	–	1540
2022 Q2	$1.99M	Buy	1,667 +217	+15%	+$258K	0.11%	363
2022 Q1	$1.72M	Buy	+1,450	New	+$1.71M	0.1%	489

Other funds holding CLDI

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Polar Asset Management Partners Toronto, Ontario, Canada $4.21B AUM 35.27% 1-Year Est. Return

First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return

Shaolin Capital Management Miami, Florida $2.39B AUM 64.83% 1-Year Est. Return

Spartan Fund Management Toronto, Ontario, Canada $30M AUM 11.98% 1-Year Est. Return

Logan Stone Capital Chicago, Illinois $360M AUM 9.71% 1-Year Est. Return

Highbridge Capital Management New York $1.58B AUM 31.19% 1-Year Est. Return

KIM LLC Wichita, Kansas $678M AUM 0.91% 1-Year Est. Return